A. Glasgow (Dublin 9, Ireland), K. Hurley (Co. Meath, Ireland)
Elucidation of a novel mechanism of Benralizumab on human immune cells using humanized hIL-3/hGM-CSF/hIL-5 Tg NOG mice
S. Nunomura (Saga, Japan), R. Ito (Kawasaki, Japan), Y. Nanri (Saga, Japan), K. Izuhara (Saga, Japan)
|   |
A transcriptomic, metabolic and phenotypic study of the anti-fibrotic effects of PGE2 in IPF lung fibroblasts and macrophages
K. Wiqvist (Mölndal, Sweden), M. Ingelsten (Mölndal, Sweden), Z. Jevnikar (Mölndal, Sweden), O. Bilkei-Gorzo (Gothenburg, Sweden), T. Ottosson (Mölndal, Sweden), T. Markou (London, United Kingdom), J. Lindgren (Mölndal, Sweden), T. Maher (London, United Kingdom), P. Molyneaux (London, United Kingdom), M. Göransson (Mölndal, Sweden)
| |
Development of PRS-400, an inhaled Jagged-1 Anticalin protein for the treatment of muco-obstructive lung diseases
M. Hagner (Hallbergmoos, Germany), C. Wurzenberger (Hallbergmoos, Germany), J. Peper-Gabriel (Hallbergmoos, Germany), D. Jaquin (Hallbergmoos, Germany), N. Quilitz (Hallbergmoos, Germany), C. Hechinger (Hallbergmoos, Germany), T. Jaquin (Hallbergmoos, Germany), K. Heinig (Hallbergmoos, Germany), E. Hansbauer (Hallbergmoos, Germany), S. Grüner (Hallbergmoos, Germany), J. Prassler (Hallbergmoos, Germany), R. Bel Aiba (Hallbergmoos, Germany), J. Mayer (Hallbergmoos, Germany), R. Bharti (Hallbergmoos, Germany), J. Wrennall (Chapel Hill, United States), R. Tarran (Chapel Hill, United States), A. Ray (Pittsburgh, United States), S. Wenzel (Pittsburgh, United States), C. Rothe (Hallbergmoos, Germany), S. Olwill (Hallbergmoos, Germany), G. Matschiner (Hallbergmoos, Germany), A. Fysikopoulos (Hallbergmoos, Germany)
| |
No effect of lidocaine on ciliary beating frequency and pattern of human nasal epithelial cells in vitro
S. Savas (Bern, Switzerland), S. Tschanz (Bern, Switzerland), P. Latzin (Bern, Switzerland), C. Casaulta (Bern, Switzerland), L. Müller (Bern, Switzerland)
| |
Fluorescent PLGA nanocarriers for pulmonary administration
A. Areny Balagueró (Sabadell, Spain), W. Mekseriwattana (Bellaterra, Spain), M. Camprubí-Rimblas (Sabadell, Spain), A. Stephany (Bellaterra, Spain), A. Roldán (Bellaterra, Spain), A. Artigas (Sabadell, Spain), D. Closa (Barcelona, Spain), A. Roig (Bellaterra, Spain)
| |
Involvement of miRNAs as a response to extracorporeal photopheresis in the control of bronchiolitis obliterans syndrome
S. Bozzini (Pavia, Italy), C. Del Fante (Pavia, Italy), M. Morosini (Pavia, Italy), C. Bagnera (Pavia, Italy), H. Berezhinskiy (Wien, Austria), S. Auner (Wien, Austria), L. Pandolfi (Pavia, Italy), M. Della Zoppa (Pavia, Italy), C. Perotti (Pavia, Italy), K. Hoetzenecker (Wien, Austria), P. Jaksch (Wien, Austria), A. Benazzo (Wien, Austria), F. Meloni (Pavia, Italy)
| |
ADAM-33 and MMP-8 in bronchial asthma.
T. Tacheva (Stara Zagora, Bulgaria), D. Dimov (Stara Zagora, Bulgaria), D. Ivanova (Stara Zagora, Bulgaria), K. Celik (Stara Zagora, Bulgaria), A. Bivolarska (Plovdiv, Bulgaria), T. Vlaykova (Stara Zagora, Bulgaria)
| |
Airway eosinophilic inflammation indicates small airway dysfunction (SAD) in patients with mild stable or at risk for COPD – results from CAPTO-COPD
M. Abdo (Grosshansdorf, Germany), F. Pedersen (Grosshansdorf, Germany), F. Trinkmann (Heidelberg, Germany), F. Herth (Heidelberg, Germany), K. Rabe (Grosshansdorf, Germany), A. Kirsten (Grosshansdorf, Germany), H. Watz (Grosshansdorf, Germany)
| |
MUC5AC and MUC5B expression in goblet cells of large airway epithelium in never-smokers, smokers, and COPD patients
T. Pincikova (Stockholm, Sweden), H. Merikallio (Oulu, Finland), I. Kotortsi (Stockholm, Sweden), R. Karimi (Stockholm, Sweden), C. Li (Stockholm, Sweden), E. Lappi-Blanco (Oulu, Finland), S. Lindén (Gothenburg, Sweden), M. Padra (Gothenburg, Sweden), Å. Wheelock (Stockholm, Sweden), R. Kaarteenaho (Oulu, Finland), M. Sköld (Stockholm, Sweden)
| |
Increased luminal narrowing but reduced wall thickness in the small airways of severe COPD patients
A. Higham (Manchester (Greater Manchester), United Kingdom), J. Dungwa (Manchester (Greater Manchester), United Kingdom), D. Singh (Manchester (Greater Manchester), United Kingdom)
| |
COPD-associated changes in lung extracellular matrix
M. Joglekar (Groningen, Netherlands), M. Koloko Ngassie (Rochester, United States), N. Bekker (Groningen, Netherlands), M. Reinders-Luinge (Groningen, Netherlands), T. Borghuis (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), S. Pouwels (Groningen, Netherlands), B. Melgert (Groningen, Netherlands), W. Timens (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), J. Burgess (Groningen, Netherlands)
| |
Olfactory Receptors Reduce Inflammation of Lung Epithelial Cells
D. Weidinger (Bochum, Germany), J. Jacobsen (Bochum, Germany), K. Jamal Jameel (Bochum, Germany), D. Alisch (Bochum, Germany), H. Uebner (Essen, Germany), J. Kronsbein (Bochum, Germany), M. Peters (Bochum, Germany), S. Reuter (Essen, Germany), H. Hatt (Bochum, Germany), J. Knobloch (Bochum, Germany)
| |
Basal airway epithelial cells from PCD have distinct proliferative and inflammatory responses
Z. Varenyiova (Prague, Czech Republic), L. Rojas (Palo Alto, CA, United States), J. Spano (Palo Alto, CA, United States), V. Capek (Prague, Czech Republic), T. Holmes (Stanford, CA, United States), C. Milla (Palo Alto, CA, United States)
| |
Cell death and proliferation-related transcripts in lung allograft airway epithelial cells
O. Mekhael (Toronto, Canada), A. Duong (Toronto, Canada), B. Renaud-Picard (Toronto, Canada), T. Daigneault (Toronto, Canada), A. Burman (Toronto, Canada), S. Moshkelgosha (Toronto, Canada), S. Juvet (Toronto, Canada), T. Martinu (Toronto, Canada)
| |
LSC - 2022 - Circular RNA expression in cystic fibrosis bronchial epithelium
C. De Santi (Dublin, Ireland), K. Hurley (Dublin, Ireland), A. Swiatecka-Urban (Charlottesville, United States), C. Greene (Dublin, Ireland)
| |
Dynamic microscopic imaging and molecular characterisation of alveolar macrophage drug effects of a labelled inflammasome inhibitor in the human lung
T. Quinn (Edinburgh, United Kingdom), A. Pellicoro (Edinburgh, United Kingdom), C. Lochenie (Edinburgh, United Kingdom), E. Duffy (Edinburgh, United Kingdom), R. O'Connor (Edinburgh, United Kingdom), A. Fernando (Edinburgh, United Kingdom), H. Stewart (Edinburgh, United Kingdom), E. Gaughan (Edinburgh, United Kingdom), K. Finlayson (Edinburgh, United Kingdom), A. Mansell (Melbourne, Australia), C. Murphy (Concord, United States), A. Rossi (Edinburgh, United Kingdom), K. Dhaliwal (Edinburgh, United Kingdom)
| |
Prevalence and predictors of airway hyperresponsiveness in asthma, COPD, and overlap-findings from a large real-life population
M. Felby (Copenhagen, Denmark), D. Klein (Copenhagen, Denmark), L. Frøssing (Copenhagen, Denmark), M. Hvidtfeldt (Copenhagen, Denmark), U. Bodtger (Naestved, Denmark), K. Romberg (Lund, Sweden), L. Bjermer (Lund, Sweden), E. Tufvesson (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark)
| |
Effect of Bronchial Thermoplasty on Alarmin (S100A7/A8/A9) Expression in Severe Asthma.
P. Gagnon (Québec, Canada), S. Assou (Montpellier, France), M. Salem (Québec, Canada), S. Biardel (Québec, Canada), J. De Vos (Montpellier, France), N. Lampron (Québec, Canada), S. Martel (Québec, Canada), L. Boulet (Québec, Canada), M. Laviolette (Québec, Canada), C. Laprise (Québec, Canada), J. Chakir (Québec, Canada)
| |
LSC - 2022 - COPD Monocyte-derived macrophages display hallmarks of senescence
S. Hassibi (london, United Kingdom), J. Baker (london, United Kingdom), P. Barnes (london, United Kingdom), L. Donnelly (london, United Kingdom)
| |
Role of urokinase-type plasminogen activator receptor (uPAR) in senescent lung cells
C. Wrench (Cambridge, United Kingdom), J. Dodgson (Cambridge, United Kingdom), C. Overed-Sayer (Cambridge, United Kingdom), L. Donnelly (London, United Kingdom), P. Barnes (London, United Kingdom)
| |